Neutralizing Antibodies and Antibody-Dependent Enhancement in COVID-19: A Perspective | SpringerLink
Cancers | Free Full-Text | CD18 Antibody Application Blocks Unwanted Off-Target T Cell Activation Caused by Bispecific Antibodies
Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection - ScienceDirect
Frontiers | Validation of a Triplex Pharmacokinetic Assay for Simultaneous Quantitation of HIV-1 Broadly Neutralizing Antibodies PGT121, PGDM1400, and VRC07-523-LS
A Multifunctional Neutralizing Antibody‐Conjugated Nanoparticle Inhibits and Inactivates SARS‐CoV‐2 - Cai - 2022 - Advanced Science - Wiley Online Library
Passive antibody therapy in COVID-19 | Nature Reviews Immunology
Human inhalable antibody fragments neutralizing SARS-CoV-2 variants for COVID-19 therapy: Molecular Therapy
Exploiting a chink in the armor: engineering broadly neutralizing monoclonal antibodies for SARS-like viruses | Signal Transduction and Targeted Therapy
What are neutralizing antibodies – the immune system's superheroes - Fluidic Analytics
Anti-mCD25 | PC-61.5.3 & 7D4| InvivoGen
Anta", "Block", "Neutra"...but Who Are They? - Innovative antibodies against haptens and transmembrane proteins
Proteins mimicking epitope of HIV-1 virus neutralizing antibody induce virus-neutralizing sera in mice - eBioMedicine
Treatment of mice with a ligand binding blocking anti-CD28 monoclonal antibody improves healing after myocardial infarction | PLOS ONE
Research and Development Progress of a SARS-CoV-2 Neutralizing Antibody